Preliminary results of trial NPC‐0501 evaluating the therapeutic gain by changing from concurrent‐adjuvant to induction‐concurrent chemoradiotherapy, changing from fluorouracil to capecitabine, and changing from conventional to accelerated radiotherapy fractionation in patients with locoregionally advanced nasopharyngeal carcinoma

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|121|8|1328-1338

ISSN： 0008-543x

Source： CANCER, Vol.121, Iss.8, 2015-04, pp. : 1328-1338

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Locoregionally Advanced Nasopharyngeal Carcinoma: Induction Chemotherapy with Cisplatin and 5-Fluorouracil Followed by Radiotherapy and Concurrent Cisplatin

By  

Oncology, Vol. 74, Iss. 3-4, 2008-08 ,pp. : 158-166

Karger

Access to resources Recommend Favorite

Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the head and neck: 10‐year update and subset analysis

By  

CANCER, Vol. 121, Iss. 10, 2015-05 ,pp. : 1599-1607

John Wiley & Sons Inc

Access to resources Recommend Favorite

Neoadjuvant chemotherapy followed by concurrent chemoradiation for locoregionally advanced nasopharyngeal carcinoma

By  

CANCER, Vol. 119, Iss. 23, 2013-12 ,pp. : 4111-4118

John Wiley & Sons Inc

Access to resources Recommend Favorite

Value of R2* obtained from T2*‐weighted imaging in predicting the prognosis of advanced cervical squamous carcinoma treated with concurrent chemoradiotherapy

By  

JOURNAL OF MAGNETIC RESONANCE IMAGING, Vol. 42, Iss. 3, 2015-09 ,pp. : 681-688

John Wiley & Sons Inc

Access to resources Recommend Favorite

Concurrent chemoradiotherapy compared with surgery and adjuvant radiotherapy for oral cavity squamous cell carcinoma

By  

HEAD & NECK: JOURNAL FOR THE SCIENCES & SPECIALTIES OF THE HEAD AND NECK, Vol. 37, Iss. 4, 2015-04 ,pp. : 518-523

John Wiley & Sons Inc

Access to resources Recommend Favorite